MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.

Little structural information is available so far on amyloid fibrils consisting of immunoglobulin light chains. It is not understood which features of the primary sequence of the protein result in fibril formation. We report here MAS solid-state NMR studies to identify the structured core of κ-type...

Full description

Bibliographic Details
Main Authors: Manuel Hora, Riddhiman Sarkar, Vanessa Morris, Kai Xue, Elke Prade, Emma Harding, Johannes Buchner, Bernd Reif
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5528828?pdf=render
_version_ 1819131229541236736
author Manuel Hora
Riddhiman Sarkar
Vanessa Morris
Kai Xue
Elke Prade
Emma Harding
Johannes Buchner
Bernd Reif
author_facet Manuel Hora
Riddhiman Sarkar
Vanessa Morris
Kai Xue
Elke Prade
Emma Harding
Johannes Buchner
Bernd Reif
author_sort Manuel Hora
collection DOAJ
description Little structural information is available so far on amyloid fibrils consisting of immunoglobulin light chains. It is not understood which features of the primary sequence of the protein result in fibril formation. We report here MAS solid-state NMR studies to identify the structured core of κ-type variable domain light chain fibrils. The core contains residues of the CDR2 and the β-strands D, E, F and G of the native immunoglobulin fold. The assigned core region of the fibril is distinct in comparison to the core identified in a previous solid-state NMR study on AL-09 by Piehl at. al, suggesting that VL fibrils can adopt different topologies. In addition, we investigated a soluble oligomeric intermediate state, previously termed the alternatively folded state (AFS), using NMR and FTIR spectroscopy. The NMR oligomer spectra display a high degree of similarity when compared to the fibril spectra, indicating a high structural similarity of the two aggregation states. Based on comparison to the native state NMR chemical shifts, we suggest that fibril formation via domain-swapping seems unlikely. Moreover, we used our results to test the quality of different amyloid prediction algorithms.
first_indexed 2024-12-22T09:12:11Z
format Article
id doaj.art-8385323faf984c73a88bfdb03891255d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T09:12:11Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-8385323faf984c73a88bfdb03891255d2022-12-21T18:31:24ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01127e018179910.1371/journal.pone.0181799MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.Manuel HoraRiddhiman SarkarVanessa MorrisKai XueElke PradeEmma HardingJohannes BuchnerBernd ReifLittle structural information is available so far on amyloid fibrils consisting of immunoglobulin light chains. It is not understood which features of the primary sequence of the protein result in fibril formation. We report here MAS solid-state NMR studies to identify the structured core of κ-type variable domain light chain fibrils. The core contains residues of the CDR2 and the β-strands D, E, F and G of the native immunoglobulin fold. The assigned core region of the fibril is distinct in comparison to the core identified in a previous solid-state NMR study on AL-09 by Piehl at. al, suggesting that VL fibrils can adopt different topologies. In addition, we investigated a soluble oligomeric intermediate state, previously termed the alternatively folded state (AFS), using NMR and FTIR spectroscopy. The NMR oligomer spectra display a high degree of similarity when compared to the fibril spectra, indicating a high structural similarity of the two aggregation states. Based on comparison to the native state NMR chemical shifts, we suggest that fibril formation via domain-swapping seems unlikely. Moreover, we used our results to test the quality of different amyloid prediction algorithms.http://europepmc.org/articles/PMC5528828?pdf=render
spellingShingle Manuel Hora
Riddhiman Sarkar
Vanessa Morris
Kai Xue
Elke Prade
Emma Harding
Johannes Buchner
Bernd Reif
MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.
PLoS ONE
title MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.
title_full MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.
title_fullStr MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.
title_full_unstemmed MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.
title_short MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.
title_sort mak33 antibody light chain amyloid fibrils are similar to oligomeric precursors
url http://europepmc.org/articles/PMC5528828?pdf=render
work_keys_str_mv AT manuelhora mak33antibodylightchainamyloidfibrilsaresimilartooligomericprecursors
AT riddhimansarkar mak33antibodylightchainamyloidfibrilsaresimilartooligomericprecursors
AT vanessamorris mak33antibodylightchainamyloidfibrilsaresimilartooligomericprecursors
AT kaixue mak33antibodylightchainamyloidfibrilsaresimilartooligomericprecursors
AT elkeprade mak33antibodylightchainamyloidfibrilsaresimilartooligomericprecursors
AT emmaharding mak33antibodylightchainamyloidfibrilsaresimilartooligomericprecursors
AT johannesbuchner mak33antibodylightchainamyloidfibrilsaresimilartooligomericprecursors
AT berndreif mak33antibodylightchainamyloidfibrilsaresimilartooligomericprecursors